WRALtechwire.com logo

Durham startup aiming to improve cognitive skills, raises $700K, launches Kickstarter campaign(+ video)

Sep, 21 2017, 6:07 AM

A Durham startup believes it has developed technology that provides alternatives to drugs for treatment of disorders such as ADHD has raised $700,000.

NeuroPlus, aiming to improve cognitive skills, shared its story at the CED Tech Venture Conference in Raleigh earlier this week.

Thirteen investors are backing NeuroPlus, according to an SEC filing.

The company wants to raise $1 million in all.

On Thursday NeuroPlus also launched a Kickstarter fundraising campaign with a goal of $100,000. More than $12,000 has already been committed.

"NeuroPlus has developed brain-sensing technology to help children and adults improve their cognitive skills. Our users wear a headset that measures their brain activity and play brain-controlled video games that train focus and self-control," CEO Jake Stauch told WRAL TechWire recently for a company profile.

"A randomized, controlled, blinded study found NeuroPlus to be 300% more effective than traditional interventions in reducing inattention, impulsivity, and hyperactivity."

The device technology, which comes in a headband, already has drawn more than $1 million from a variety of investors.

"There are few evidence-based interventions to help these kids, and many families are hesitant to use medications due to concerns over side effects and other risks," Stauch explains.

"NeuroPlus is a safe, effective, and engaging training tool to help these children develop critical attention skills."

The startup said it had raised some $1.2 million before the CED conference.


Profile: NeuroPlus

‚Äč

The Q&A:

NeuroPlus has developed brain-sensing technology to help children and adults improve their cognitive skills. Our users wear a headset that measures their brain activity and play brain-controlled video games that train focus and self-control.

A randomized, controlled, blinded study found NeuroPlus to be 300% more effective than traditional interventions in reducing inattention, impulsivity, and hyperactivity.

We are currently focused on selling to families of children with attention issues like ADHD.

There are few evidence-based interventions to help these kids, and many families are hesitant to use medications due to concerns over side effects and other risks.

NeuroPlus is a safe, effective, and engaging training tool to help these children develop critical attention skills.

We're the only non-pharmacological product on the market that's clinically proven to improve attention and self-control.

Last year $14 billion was spent on ADHD medications that parents hate giving to their children. What if there were an alternative that was safer, more effective, and actually fun to use? NeuroPlus is that alternative.

We've raised about $1.2 M from Splashpond Investors in Charlotte, Triangle Angel Partners, Capital A Partners, RTP Capital, and several individual angels from around the country.






Menu